AR

Ankush Ramchandra Patil

Active Director Director DIN 11370151
DIN 11370151 First appointment Nov 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankush Ramchandra Patil

Data last updated:

Ankush Ramchandra Patil is a Director at Prantap Biopharma Private Limited (since 2025). The company operates in Biotechnology.

DIN 11370151
Primary Designation Director
Industry Biotechnology
First Appointment 06 Nov 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prantap Biopharma Private Limited U21004PN2025PTC248065
Director06 Nov 20252025Active

Board colleagues of Ankush Ramchandra Patil

NameDINCompanyDesignation
Priyanka Ankush Patil11370152Prantap Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Prantap Biopharma Private Limited
Premium access

Shareholding and investment profile for Ankush Ramchandra Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankush Ramchandra Patil

Ankush Ramchandra Patil currently holds 1 directorship: Prantap Biopharma Private Limited (Director, since 06 Nov 2025).

Ankush Ramchandra Patil was first appointed on 06 Nov 2025 as Director at Prantap Biopharma Private Limited.

The current boards of Ankush Ramchandra Patil's companies include Priyanka Ankush Patil (Prantap Biopharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available